Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: Report of three cases

Conclusion: This report contributes to the pathophysiologic clarification of bevacizumab-induced bowel complications and points to a potentially increased risk of severe ischemic damage during treatment with bevacizumab in patients who have undergone previous radiotherapy.